Dendreon Corp fka DNDNQ

[DewDiligence]

>The list of biotech execs who have publicly criticized the FDA recently grows longer. They do so knowing that they risk blowback when their companies must go before the FDA seeking regulatory approvals, which, IMO, adds credence to their arguments.<

I would substitute the word desperation in place of credence.